跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,026 条关于
“Guggenheim Securities, LLC”
全部
4,026
临床试验
531
药物
458
机构
1,710
资讯
1,327
4个月前
Certara Divests Regulatory and Medical Writing Business to Veristat for $135 Million to Focus on AI-Driven Drug Development
5个月前
Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Adding First-in-Class PWS Treatment
22天前
Teva Bids to Acquire BioXcel's Dexmedetomidine Sublingual Film for At-Home Agitation Treatment
去年
ProMIS Neurosciences to Present at Guggenheim Securities SMID Cap Biotech Conference
去年
Soleno Therapeutics Raises $200 Million to Fund Commercialization of First FDA-Approved Prader-Willi Syndrome Therapy
去年
Jazz Pharmaceuticals to Acquire Chimerix for $935M, Gaining Novel Brain Tumor Drug Candidate
去年
Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
去年
ArriVent BioPharma Raises $75 Million to Advance Firmonertinib and Cancer Pipeline
去年
Caris Life Sciences Files for $300 Million IPO to Advance AI-Powered Precision Oncology Platform
第 1 页,共 133 页
上一页
下一页